Matches in Nanopublications for { ?s ?p "[Together, our data indicate that RAS-mutated myeloid leukemias are dependent on the PI3K isoform p110?, and combined pharmacologic inhibition of p110? and MEK could be an effective therapeutic strategy for JMML and AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP1158092.RAfnYT5XwUhr_hJ7fXWc77mSuZO0bpAnwLt9v7eoDLiGU130_assertion description "[Together, our data indicate that RAS-mutated myeloid leukemias are dependent on the PI3K isoform p110?, and combined pharmacologic inhibition of p110? and MEK could be an effective therapeutic strategy for JMML and AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158092.RAfnYT5XwUhr_hJ7fXWc77mSuZO0bpAnwLt9v7eoDLiGU130_provenance.
- NP1158097.RAfcSrZX9P42RHzo2m5y8loq2HtWwAxokd1pGnrvLeUec130_assertion description "[Together, our data indicate that RAS-mutated myeloid leukemias are dependent on the PI3K isoform p110?, and combined pharmacologic inhibition of p110? and MEK could be an effective therapeutic strategy for JMML and AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158097.RAfcSrZX9P42RHzo2m5y8loq2HtWwAxokd1pGnrvLeUec130_provenance.
- NP1158100.RAfgwlIbNkjHybrE6HCD9SAVdVDEhNKp-MaoBr3gDJtX8130_assertion description "[Together, our data indicate that RAS-mutated myeloid leukemias are dependent on the PI3K isoform p110?, and combined pharmacologic inhibition of p110? and MEK could be an effective therapeutic strategy for JMML and AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158100.RAfgwlIbNkjHybrE6HCD9SAVdVDEhNKp-MaoBr3gDJtX8130_provenance.
- NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_assertion description "[Together, our data indicate that RAS-mutated myeloid leukemias are dependent on the PI3K isoform p110?, and combined pharmacologic inhibition of p110? and MEK could be an effective therapeutic strategy for JMML and AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158110.RAvEioWI0RwEGKg3n8fxZfA7X11SHyfrNFy-mTxJFqd0w130_provenance.
- NP1158091.RAICWAk3J-2FKvpeswmps0GZqyqp3T2JajjDaddvwqVX8130_assertion description "[Together, our data indicate that RAS-mutated myeloid leukemias are dependent on the PI3K isoform p110?, and combined pharmacologic inhibition of p110? and MEK could be an effective therapeutic strategy for JMML and AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158091.RAICWAk3J-2FKvpeswmps0GZqyqp3T2JajjDaddvwqVX8130_provenance.
- NP1158099.RAFCt3GfovYj9OwrvFwooLkpcphjmCAC7dnXQH7J5JhM8130_assertion description "[Together, our data indicate that RAS-mutated myeloid leukemias are dependent on the PI3K isoform p110?, and combined pharmacologic inhibition of p110? and MEK could be an effective therapeutic strategy for JMML and AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158099.RAFCt3GfovYj9OwrvFwooLkpcphjmCAC7dnXQH7J5JhM8130_provenance.
- NP1158107.RANHwzn3MD1yfn4gtXWaTviPPMLZH3G3SJmdZ5fdMau1Q130_assertion description "[Together, our data indicate that RAS-mutated myeloid leukemias are dependent on the PI3K isoform p110?, and combined pharmacologic inhibition of p110? and MEK could be an effective therapeutic strategy for JMML and AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158107.RANHwzn3MD1yfn4gtXWaTviPPMLZH3G3SJmdZ5fdMau1Q130_provenance.